These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19441089)

  • 1. Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival.
    Thomassen M; Jochumsen KM; Mogensen O; Tan Q; Kruse TA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):711-24. PubMed ID: 19441089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis.
    Thomassen M; Tan Q; Kruse TA
    Breast Cancer Res Treat; 2009 Jan; 113(2):239-49. PubMed ID: 18293085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.
    Bruchim I; Israeli O; Mahmud SM; Aviram-Goldring A; Rienstein S; Friedman E; Ben-Baruch G; Gotlieb WH
    Cancer Genet Cytogenet; 2009 Apr; 190(2):66-70. PubMed ID: 19380021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression in early-stage ovarian cancer.
    Marchini S; Mariani P; Chiorino G; Marrazzo E; Bonomi R; Fruscio R; Clivio L; Garbi A; Torri V; Cinquini M; Dell'Anna T; Apolone G; Broggini M; D'Incalci M
    Clin Cancer Res; 2008 Dec; 14(23):7850-60. PubMed ID: 19047114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
    Yi X; Zhou Y; Zheng W; Chambers SK
    Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):93-8. PubMed ID: 19281587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(1):130-5. PubMed ID: 15927360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for genes associated with ovarian cancer prognosis.
    Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
    Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gene expression profiling in the clinical management of ovarian cancer.
    Olivier RI; van Beurden M; van' t Veer LJ
    Eur J Cancer; 2006 Nov; 42(17):2930-8. PubMed ID: 17055255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A locally adaptive statistical procedure (LAP) to identify differentially expressed chromosomal regions.
    Callegaro A; Basso D; Bicciato S
    Bioinformatics; 2006 Nov; 22(21):2658-66. PubMed ID: 16951291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in gynecological malignancies.
    Krkavcová M; Jancárková N; Janashia M; Freitag P; Dusková J
    Neoplasma; 2008; 55(3):205-14. PubMed ID: 18348653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
    Gyorffy B; Lánczky A; Szállási Z
    Endocr Relat Cancer; 2012 Apr; 19(2):197-208. PubMed ID: 22277193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.
    Castellano G; Reid JF; Alberti P; Carcangiu ML; Tomassetti A; Canevari S
    Cancer Res; 2006 Nov; 66(22):10709-19. PubMed ID: 17090524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
    Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
    Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays.
    Caprini E; Cristofoletti C; Arcelli D; Fadda P; Citterich MH; Sampogna F; Magrelli A; Censi F; Torreri P; Frontani M; Scala E; Picchio MC; Temperani P; Monopoli A; Lombardo GA; Taruscio D; Narducci MG; Russo G
    Cancer Res; 2009 Nov; 69(21):8438-46. PubMed ID: 19843862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed genes in the high and low metastatic human ovarian cancer cell lines and analyses of their chromosomal localizations and functions.
    Xu SH; Mu HZ; Gu LH; Zhu CH; Liu XL
    Yi Chuan Xue Bao; 2006 Oct; 33(10):892-900. PubMed ID: 17046589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metastin/a G-protein-coupled receptor signaling and Down syndrome critical region 1 in epithelial ovarian cancer.
    Hata K; Watanabe Y; Nakai H; Minami T; Ohsaki H; Hirakawa E; Hoshiai H
    Anticancer Res; 2009 Feb; 29(2):617-23. PubMed ID: 19331211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?
    Panani AD
    Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.